| CTRI Number |
CTRI/2024/07/070893 [Registered on: 19/07/2024] Trial Registered Prospectively |
| Last Modified On: |
05/08/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Regional versus General Anaesthesia- Which has better post-operative benefits following emergency fracture surgeries |
|
Scientific Title of Study
|
To assess the effect of type and incidence of morbidity on length of hospital stay between different anaesthesia technique following damage control orthopaedic surgery
|
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr.A.Swathy |
| Designation |
Junior Resident |
| Affiliation |
Postgraduate Institute of Medical Education and Research |
| Address |
Department pf Anaesthesia, level 4, Nehru Hospital, PGIMER, Sector 12, Chandigarh
Chandigarh CHANDIGARH 160012 India |
| Phone |
7667867777 |
| Fax |
|
| Email |
swatheez@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr.A.Swathy |
| Designation |
Junior Resident |
| Affiliation |
Postgraduate Institute of Medical Education and Research |
| Address |
Department pf Anaesthesia, level 4, Nehru Hospital, PGIMER, Sector 12, Chandigarh
Chandigarh CHANDIGARH 160012 India |
| Phone |
7667867777 |
| Fax |
|
| Email |
swatheez@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr.Amarjyoti Hazarika |
| Designation |
Additional Professor |
| Affiliation |
Postgraduate Institute of Medical Education and Research |
| Address |
Department pf Anaesthesia, level 4, Nehru Hospital, PGIMER, Sector 12, Chandigarh
Chandigarh CHANDIGARH 160012 India |
| Phone |
9990238972 |
| Fax |
|
| Email |
amarjyoti28@rediffmail.com |
|
|
Source of Monetary or Material Support
|
| Department pf Anaesthesia, level 4, Nehru Hospital, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India, 160012 |
|
|
Primary Sponsor
|
| Name |
not applicable |
| Address |
not apploicable |
| Type of Sponsor |
Other [not applicable] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DrAmarjyoti Hazarika |
Postgraduate Institute of Medical Education and Research |
Department pf Anaesthesia, level 4, Nehru Hospital, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India, 160012 Chandigarh CHANDIGARH |
9990238972
amarjyoti28@rediffmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Instituitional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: S829||Unspecified fracture of lower leg, (2) ICD-10 Condition: S799||Unspecified injury of hip and thigh, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
General Anaesthesia |
The patient will be induced using
Intravenous opioids (fentanyl 1-2mics/kg),
Graded doses of intravenous anaesthetic drugs (propofol, etomidate)
Neuromuscular blocking agent (atracurium 0.5mg/kg or vecuronium 0.1mg/kg)
Anaesthesia will be maintained with inhalational agents either sevoflurane or isoflurane with air+ oxygen in 1:1 ratio, with fresh gas flows of 2L/min, securing airway with endotracheal tube of appropriate size in situ and maintaining a MAC in the range of 1-1.5. Intraoperative analgesia will be maintained with epidural infusion of 0.25% plain bupivacaine and postoperative analgesia will be maintained with infusion of plain bupivacaine 0.125% over a period of 72 hours. If further pain management is required, intravenous paracetamol 10-15mg/kg TDS or diclofenac 1mg/kg for breakthrough pain will be given.
|
| Comparator Agent |
Regional Anaesthesia |
Anaesthesia of the surgical site will be achieved using combined spinal epidural anaesthesia. Epidural catheters will be placed as already mentioned. Spinal anaesthesia will be administered using 26G Quinke’s needle in the same space as epidural catheter, with 2-3ml 0.5% heavy Bupivacaine + 25mcg fentanyl so as to achieve a spinal level of T10, which will be checked using hot and cold temperature sensation. Intraoperative analgesia will be maintained with epidural infusion of 0.25% plain bupivacaine and postoperative analgesia will be maintained with infusion of plain bupivacaine 0.125% over a period of 72 hours. If further pain management is required, intravenous paracetamol 10-15mg/kg TDS or diclofenac 1mg/kg for breakthrough pain will be given. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients of ASA grade 1&2 between ages 18 to 60 years of either gender with open lower extremity fractures IIIa, and IIIb, of the one or both lower limbs being taken up for emergency surgery within 24 hours of injury and 12 hours of hospital admission. |
|
| ExclusionCriteria |
| Details |
patients with uncontrolled comorbid conditions, upper limb fracture, hemodynamically unstable patients, vascular injury, pregnancy, pelvic thoracic and abdominal trauma, patient refusal |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To compare the incidence and type of early morbidity between general versus regional anaesthesia technique assessed by POMS score at post-operative day (POD) 8 following emergency orthopaedic surgery |
POD8 |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To compare the trends in POMS score between anaesthesia techniques on POD 1,3,5 and 8 |
POD 1,3,5 and 8 |
|
|
Target Sample Size
|
Total Sample Size="126" Sample Size from India="126"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
31/07/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is an RCT to
compare the incidence and type of early morbidity between general versus
regional anaesthesia technique assessed by POMS score at post-operative day
(POD) 8 following emergency orthopaedic surgery that will be conducted in the Department
of Anaesthesia & Intensive Care, PGIMER, Chandigarh in patients who had traumatic lower limb open fractures type IIIA and IIIB
undergoing emergency orthopaedic surgery. Patients
fulfilling the inclusion criteria will be recruited. Basic demographic data, ASA PS grade, Acute Physiology and
Chronic Health Evaluation (APACHE) score, nature of injury, Injury Severity
Score (ISS), site, duration and type of surgery, time since injury,
co-morbidities, routine baseline investigations, including renal function test
(RFT) and coagulation profile shall be recorded. Anaesthesia
provider will not be blinded to the intervention. Patients will be randomly assigned to two groups in a 1:1 ratio using a computer-generated
randomised list concealed by opaque sealed envelopes. The outcome assessor, data
analyst will remain blinded. Postoperative morbidity will be measured by using Post Operative
Morbidity Survey (POMS) score. For
comparing POMS, each patient’s score will be recorded prospectively in the
post-operative period at the following time points. T1- 1st
Post operative Day (POD1), T2-POD3, T3-POD5, T4-POD8.
|